IBRX•benzinga•
ImmunityBio Says Preparing To Submit sBLA In 2025 For Its Treatment Targeting Bacillus Calmette-guérin Unresponsive Non-muscle Invasive Bladder Cancer In The Papillary Indication
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 15, 2025 by benzinga